BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8057683)

  • 61. Establishment of a novel cell line with T-lineage phenotype (HPB-MLp-W) from a non-Hodgkin's lymphoma patient.
    Morikawa S; Morikawa K; Hara J; Nagasaki M; Nakano A; Oseko F
    Leuk Res; 1991; 15(5):381-9. PubMed ID: 2046390
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cytogenetic characterization of Epstein-Barr virus-associated T-cell malignancies.
    Tien HF; Su IJ; Chuang SM; Lee FY; Liu MC; Tsai TF; Lin KH; Chen RL
    Cancer Genet Cytogenet; 1993 Aug; 69(1):25-30. PubMed ID: 8397064
    [TBL] [Abstract][Full Text] [Related]  

  • 63. When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.
    Hurley EA; Agger S; McNeil JA; Lawrence JB; Calendar A; Lenoir G; Thorley-Lawson DA
    J Virol; 1991 Mar; 65(3):1245-54. PubMed ID: 1847452
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adult aggressive natural killer cell leukemia.
    Zhang H; Meng Q; Yin W; Xu L; Lie L
    Am J Med Sci; 2013 Jul; 346(1):56-63. PubMed ID: 23241562
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The circular intracellular form of Epstein-Barr virus DNA is amplified by the virus-associated DNA polymerase.
    Shaw JE
    J Virol; 1985 Mar; 53(3):1012-5. PubMed ID: 2983082
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Spontaneous reduction in Epstein-Barr virus (EBV) DNA copy number in EBV-infected epithelial cell lines.
    Kanamori M; Murakami M; Takahashi T; Kamada N; Tajima M; Okinaga K; Miyazawa Y; Kurata T; Sairenji T
    Microbes Infect; 2001 Nov; 3(13):1085-91. PubMed ID: 11709288
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma.
    Naumovski L; Utz PJ; Bergstrom SK; Morgan R; Molina A; Toole JJ; Glader BE; McFall P; Weiss LM; Warnke R
    Blood; 1989 Dec; 74(8):2733-42. PubMed ID: 2554995
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.
    Takada K; Ono Y
    J Virol; 1989 Jan; 63(1):445-9. PubMed ID: 2462063
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection and quantification of Epstein-Barr virus EBER1 in EBV-infected cells by fluorescent in situ hybridization and flow cytometry.
    Stowe RP; Cubbage ML; Sams CF; Pierson DL; Barrett AD
    J Virol Methods; 1998 Nov; 75(1):83-91. PubMed ID: 9820577
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-random integration of Epstein-Barr virus in lymphoblastoid cell lines.
    Lestou VS; De Braekeleer M; Strehl S; Ott G; Gadner H; Ambros PF
    Genes Chromosomes Cancer; 1993 Sep; 8(1):38-48. PubMed ID: 7691158
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis.
    Kwong YL; Lam CC; Chan TM
    Br J Haematol; 2000 Jul; 110(1):197-202. PubMed ID: 10930998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.
    Schneider U; Schwenk HU; Bornkamm G
    Int J Cancer; 1977 May; 19(5):621-6. PubMed ID: 68013
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dimer-size DNA circles in a leukemic cell immortalized with the Epstein-Barr virus.
    Gussander E; Adams A
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4770-4. PubMed ID: 6289318
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location.
    Teo CG; Griffin BE
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8473-7. PubMed ID: 2825191
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A B-cell line having chromosome 14 aberration at break band q11 derived from an adult T-cell leukemia patient.
    Miyamoto K; Matsuoka M; Tomita N; Suzuki C; Sato Y; Ishii A; Kitajima K; Nonaka H; Kondo T; Hiraki Y
    Jpn J Cancer Res; 1988 Jan; 79(1):12-6. PubMed ID: 2895757
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Establishment of a T-cell line from human lymphosarcoma.
    Hiraki S; Miyoshi I; Kubonishi I; Matsuda Y; Nakayama T; Kishimoto H; Machida K; Masuji H; Kimura I
    Gan; 1978 Feb; 69(1):115-8. PubMed ID: 305872
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A T chronic lymphocytic leukemia with large granular lymphocytes. Phenotype and functions of leukemic cells under in vitro treatment by differentiation inducers.
    Merle-Beral H; Boucheix C; Karray S; Hercend T; Capron F; Autran B; Vazquez A; Blanc C; Oberling F; Debré P
    Cancer; 1987 Apr; 59(7):1296-303. PubMed ID: 3545432
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A human T cell line with an abnormal trisomy 2 karyotype established by coculture of peripheral lymphocytes with an HTLV-II-infected simian leukocyte cell line.
    Ohara N; Hayashi K; Miyamoto K; Tomita N; Fujiwara K; Kondo E; Takahashi K; Ohtsuki Y; Akagi T
    Acta Pathol Jpn; 1993 May; 43(5):237-43. PubMed ID: 8322609
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection.
    Ishihara S; Tawa A; Yumura-Yagi K; Murata M; Hara J; Yabuuchi H; Hirai K; Kawa-Ha K
    Jpn J Cancer Res; 1989 Feb; 80(2):99-101. PubMed ID: 2542204
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Establishment of a monosomy 7 leukemia cell line, MONO-7, with a ras gene mutation.
    Fujisaki H; Takai K; Akihisa S; Tokimasa S; Matsuda Y; Ohta H; Osugi Y; Kim JY; Hosoi G; Sako M; Hara J
    Int J Hematol; 2002 Jan; 75(1):72-7. PubMed ID: 11843295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.